Internal Medicine, Nephrology · Brooklyn, NY
NPI
1225083165
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3048 Brighton 1st St, Suite 6a
Brooklyn, NY, 11235
Phone (718) 769-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
9,392 services
Medicare patients, 2024
538
Average age 81
Drug cost, 2024
$1.3M
8,896 prescriptions
Company payments, 2025
$470
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alla Maslova was code J0885 (injection, epoetin alfa, (for non-esrd use), 1000 units), 2,280 times for 23 patients. In total Alla Maslova billed 9,392 services in 41 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,280 | 23 | $0.46 | $1,044 |
| 99213 Office E&M - Established | Office | 980 | 366 | $76.61 | $75K |
| 82947 Clinical Chemistry | Office | 592 | 182 | $3.85 | $2,279 |
| 36415 Venipuncture Blood Collection | Office | 494 | 285 | $8.65 | $4,273 |
| J1940 Injection, furosemide, up to 20 mg | Office | 490 | 36 | $0.41 | $201 |
| 99214 Office E&M - Established | Office | 447 | 267 | $112.34 | $50K |
| 96372 Injection Administration | Office | 432 | 173 | $12.27 | $5,301 |
| 90960 ESRD Related Services (not dialysis) | Office | 345 | 40 | $307.11 | $106K |
| 83986 Clinical Chemistry | Office | 279 | 238 | $3.51 | $979 |
| 82247 Clinical Chemistry | Office | 278 | 237 | $4.92 | $1,368 |
| 81003 Clinical Chemistry | Office | 278 | 237 | $2.20 | $612 |
| 82010 Clinical Chemistry | Office | 277 | 236 | $8.01 | $2,219 |
| 82570 Clinical Chemistry | Office | 266 | 227 | $5.08 | $1,351 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 256 | 24 | $0.74 | $188 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 248 | 128 | $0.94 | $233 |
By year: 2022 $320K for 7,730 services; 2023 $310K for 8,164 services; 2024 $319K for 9,392 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 592 | 182 | $3.85 | $2,279 |
| 36415 Venipuncture Blood Collection | 494 | 285 | $8.65 | $4,273 |
| 83986 Clinical Chemistry | 279 | 238 | $3.51 | $979 |
| 82247 Clinical Chemistry | 278 | 237 | $4.92 | $1,368 |
| 81003 Clinical Chemistry | 278 | 237 | $2.20 | $612 |
| 82010 Clinical Chemistry | 277 | 236 | $8.01 | $2,219 |
| 82570 Clinical Chemistry | 266 | 227 | $5.08 | $1,351 |
Medicare prescription drug claims, 2024
In 2024, the drug Alla Maslova prescribed most often to Medicare patients was Allopurinol, with 891 prescriptions and refills. In total Alla Maslova wrote 8,896 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 891 | 957 | 168 | $3,105 |
| Torsemide Generic | 611 | 623 | 110 | $4,743 |
| Furosemide Generic | 466 | 509 | 103 | $652 |
| Losartan Potassium Generic | 405 | 441 | 75 | $1,721 |
| Hydralazine Hcl Generic | 392 | 416 | 90 | $2,794 |
| Vascepa Icosapent Ethyl | 318 | 335 | 65 | $110K |
| Ezetimibe Generic | 278 | 308 | 51 | $2,250 |
| Rosuvastatin Calcium Generic | 252 | 278 | 57 | $1,157 |
| Atorvastatin Calcium Generic | 219 | 251 | 51 | $749 |
| Lokelma Sodium Zirconium Cyclosilicate | 215 | 215 | 58 | $185K |
| Tamsulosin Hcl Generic | 199 | 209 | 35 | $1,304 |
| Ciprofloxacin Hcl Generic | 195 | 195 | 154 | $590 |
| Calcium Acetate Generic | 173 | 177 | 29 | $8,855 |
| Creon Lipase/Protease/Amylase | 172 | 178 | 36 | $199K |
| Nifedipine Er Nifedipine | 163 | 167 | 30 | $2,289 |
Brand drugs: 1,767 claims; generic drugs: 7,116 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alla Maslova $470 ($470 in general payments such as food, travel and fees) from 13 companies. The largest payer was ANI Pharmaceuticals, Inc. with $96.98.
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. ANIP | 3 | $96.98 |
| OPKO Pharmaceuticals, LLC | 3 | $68.68 |
| Medtronic, Inc. MDT | 2 | $55.47 |
| Abbvie Inc. ABBV | 2 | $32.6 |
| Scpharmaceuticals Inc. SCPH | 1 | $30.86 |
| Mallinckrodt Hospital Products Inc. | 1 | $29.39 |
| Almatica Pharma LLC | 1 | $28.28 |
| Shield Therapeutics Inc STX.L | 1 | $25.36 |
| Ardelyx, Inc. ARDX | 1 | $24.92 |
| Aimmune Therapeutics, Inc. | 1 | $23.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.